These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
228 related articles for article (PubMed ID: 11965396)
1. Structure-based screening and design in drug discovery. van Dongen M; Weigelt J; Uppenberg J; Schultz J; Wikström M Drug Discov Today; 2002 Apr; 7(8):471-8. PubMed ID: 11965396 [TBL] [Abstract][Full Text] [Related]
2. Application of NMR screening in drug discovery. Fejzo J; Lepre C; Xie X Curr Top Med Chem; 2003; 3(1):81-97. PubMed ID: 12570779 [TBL] [Abstract][Full Text] [Related]
4. Leveraging structural approaches: applications of NMR-based screening and X-ray crystallography for inhibitor design. Moore J; Abdul-Manan N; Fejzo J; Jacobs M; Lepre C; Peng J; Xie X J Synchrotron Radiat; 2004 Jan; 11(Pt 1):97-100. PubMed ID: 14646145 [TBL] [Abstract][Full Text] [Related]
5. Counting on Fragment Based Drug Design Approach for Drug Discovery. Kashyap A; Singh PK; Silakari O Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406 [TBL] [Abstract][Full Text] [Related]
6. Crystallography, NMR and virtual screening: integrated tools for drug discovery. Muchmore SW; Hajduk PJ Curr Opin Drug Discov Devel; 2003 Jul; 6(4):544-9. PubMed ID: 12951817 [TBL] [Abstract][Full Text] [Related]
8. Structure-guided fragment screening for lead discovery. Verdonk ML; Hartshorn MJ Curr Opin Drug Discov Devel; 2004 Jul; 7(4):404-10. PubMed ID: 15338949 [TBL] [Abstract][Full Text] [Related]
9. Design of small molecule libraries for NMR screening and other applications in drug discovery. Jacoby E; Davies J; Blommers MJ Curr Top Med Chem; 2003; 3(1):11-23. PubMed ID: 12570776 [TBL] [Abstract][Full Text] [Related]
10. Second-site NMR screening and linker design. Jahnke W; Flörsheimer A; Blommers MJ; Paris CG; Heim J; Nalin CM; Perez LB Curr Top Med Chem; 2003; 3(1):69-80. PubMed ID: 12570778 [TBL] [Abstract][Full Text] [Related]
11. NMR screening in drug discovery. Moore JM Curr Opin Biotechnol; 1999 Feb; 10(1):54-8. PubMed ID: 10047510 [TBL] [Abstract][Full Text] [Related]
12. New roles for structure in biology and drug discovery. Russell RB; Eggleston DS Nat Struct Biol; 2000 Nov; 7 Suppl():928-30. PubMed ID: 11103989 [No Abstract] [Full Text] [Related]
13. Fragment-based lead discovery: a chemical update. Erlanson DA Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612 [TBL] [Abstract][Full Text] [Related]
14. [Strategy of molecular drug design: hits, leads and drug candidates]. Guo ZR Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779 [TBL] [Abstract][Full Text] [Related]
15. Integration of NMR and high-throughput screening. Hajduk PJ; Burns DJ Comb Chem High Throughput Screen; 2002 Dec; 5(8):613-21. PubMed ID: 12470258 [TBL] [Abstract][Full Text] [Related]
16. ID NMR Methods in ligand-receptor interactions. Zartler ER; Yan J; Mo H; Kline AD; Shapiro MJ Curr Top Med Chem; 2003; 3(1):25-37. PubMed ID: 12577989 [TBL] [Abstract][Full Text] [Related]
17. Lead generation and examples opinion regarding how to follow up hits. Orita M; Ohno K; Warizaya M; Amano Y; Niimi T Methods Enzymol; 2011; 493():383-419. PubMed ID: 21371599 [TBL] [Abstract][Full Text] [Related]
19. NMR-based screening technologies. Coles M; Heller M; Kessler H Drug Discov Today; 2003 Sep; 8(17):803-10. PubMed ID: 12946643 [TBL] [Abstract][Full Text] [Related]
20. High-Throughput Screening by Nuclear Magnetic Resonance (HTS by NMR) for the Identification of PPIs Antagonists. Wu B; Barile E; De SK; Wei J; Purves A; Pellecchia M Curr Top Med Chem; 2015; 15(20):2032-42. PubMed ID: 25986689 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]